IXC 5.71% 7.4¢ invex therapeutics ltd

Ann: Initial FDA and EMA Advice on Presendin Development, page-140

  1. 387 Posts.
    lightbulb Created with Sketch. 47
    I disagree. I think it's just market sentiment and impatience. The fact is that even if the FDA comes back and tells IXC that they need to do 2 trials, it's not catastrophic. They still have an outstanding drug, excellent data, and plenty of cash in the bank. They're still a very suitable takeover target. This is the end game
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.4¢
Change
0.004(5.71%)
Mkt cap ! $5.561M
Open High Low Value Volume
7.1¢ 7.5¢ 7.1¢ $4.091K 54.95K

Buyers (Bids)

No. Vol. Price($)
1 198734 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 29802 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.